A	O
hydrophobic	O
domain	O
of	O
Ca2+-modulating	B-protein
cyclophilin	I-protein
ligand	I-protein
modulates	O
calcium	O
influx	O
signaling	O
in	O
T	O
lymphocytes	O
.	O

Ca2+-modulating	B-protein
cyclophilin	I-protein
ligand	I-protein
(	O
CAML	B-protein
)	O
was	O
originally	O
described	O
as	O
a	O
cyclophilin	B-protein
B-binding	I-protein
protein	I-protein
whose	O
overexpression	O
in	O
T	B-cell_type
cells	I-cell_type
causes	O
a	O
rise	O
in	O
intracellular	O
calcium	O
,	O
thus	O
activating	O
transcription	B-protein
factors	I-protein
responsible	O
for	O
the	O
early	O
immune	O
response	O
.	O

As	O
reported	O
here	O
,	O
structure-function	O
analysis	O
of	O
the	O
CAML	B-DNA
gene	I-DNA
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
indicates	O
that	O
two	O
of	O
CAML	B-protein
's	O
putative	B-protein
membrane-spanning	I-protein
domains	I-protein
are	O
necessary	O
and	O
sufficient	O
for	O
the	O
modulation	O
of	O
intracellular	O
calcium	O
.	O

We	O
propose	O
that	O
the	O
hydrophobic	B-protein
C-terminal	I-protein
tail	I-protein
of	O
CAML	B-protein
forms	O
its	O
effector	O
domain	O
,	O
thus	O
implicating	O
the	O
N-terminal	B-protein
hydrophilic	I-protein
domain	I-protein
in	O
a	O
regulatory	O
role	O
.	O

These	O
findings	O
define	O
a	O
novel	B-protein
protein	I-protein
motif	I-protein
that	O
functions	O
in	O
intracellular	O
calcium	O
signaling	O
.	O

Communication	NULL
A	NULL
Hydrophobic	NULL
Domain	NULL
of	NULL
Ca**-modulating	NULL
Cyclophilin	NULL
Ligand	NULL
Modulates	NULL
Calcium	NULL
Influx	NULL
Signaling	NULL
in	NULL
T	NULL
Lymphocytes*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
September	NULL
28	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
February	NULL
3	NULL
,	NULL
1996	NULL
)	NULL
Michael	NULL
P.	NULL
Hollowayt	NULL
and	NULL
Richard	NULL
J.	NULL
Bram	NULL
#	NULL
§|	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
{	NULL
Experimental	NULL
Oncology	NULL
and	NULL
§Hematology	NULL
/	NULL
Oncology	NULL
,	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
,	NULL
Memphis	NULL
,	NULL
Tennessee	NULL
38105	NULL
and	NULL
«	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
University	NULL
of	NULL
Tennessee	NULL
,	NULL
Memphis	NULL
,	NULL
Tennessee	NULL
38105	NULL
Ca	NULL
``	NULL
*-modulating	NULL
cyclophilin	NULL
ligand	NULL
(	NULL
CAML	NULL
)	NULL
was	NULL
originally	NULL
described	NULL
as	NULL
a	NULL
cyclophilin	NULL
B-binding	NULL
protein	NULL
whose	NULL
overexpression	NULL
in	NULL
T	NULL
cells	NULL
causes	NULL
a	NULL
rise	NULL
in	NULL
intracellular	NULL
calcium	NULL
,	NULL
thus	NULL
activating	NULL
transcription	NULL
factors	NULL
responsible	NULL
for	NULL
the	NULL
early	NULL
immune	NULL
response	NULL
.	NULL

As	NULL
reported	NULL
here	NULL
,	NULL
structure-function	NULL
analysis	NULL
of	NULL
the	NULL
CAML	NULL
gene	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
indicates	NULL
that	NULL
two	NULL
of	NULL
CAML	NULL
's	NULL
putative	NULL
membrane-spanning	NULL
domains	NULL
are	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
the	NULL
modulation	NULL
of	NULL
intracellular	NULL
calcium	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
the	NULL
hydrophobic	NULL
C-terminal	NULL
tail	NULL
of	NULL
CAML	NULL
forms	NULL
its	NULL
effector	NULL
domain	NULL
,	NULL
thus	NULL
implicating	NULL
the	NULL
N-terminal	NULL
hydrophilic	NULL
domain	NULL
in	NULL
a	NULL
regulatory	NULL
role	NULL
.	NULL

These	NULL
findings	NULL
define	NULL
a	NULL
novel	NULL
protein	NULL
motif	NULL
that	NULL
functions	NULL
in	NULL
intracellular	NULL
calcium	NULL
signaling	NULL
.	NULL

The	NULL
complex	NULL
of	NULL
cyclophilin	NULL
A	NULL
or	NULL
cyclophilin	NULL
B	NULL
with	NULL
the	NULL
im-munosuppressant	NULL
drug	NULL
cyclosporin	NULL
A	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
and	NULL
inhibit	NULL
the	NULL
calcium	NULL
dependent	NULL
phosphatase	NULL
calcineurin	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

Because	NULL
weak	NULL
binding	NULL
of	NULL
cyclophilins	NULL
to	NULL
calcineurin	NULL
can	NULL
be	NULL
detected	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cyclosporin	NULL
A	NULL
,	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
the	NULL
cyclophilins	NULL
normally	NULL
participate	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
calcineurin	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Ca**-modulating	NULL
cyclophilin	NULL
ligand	NULL
(	NULL
CAML	NULL
)	NULL
*	NULL
was	NULL
isolated	NULL
by	NULL
a	NULL
yeast	NULL
two-hybrid	NULL
screen	NULL
of	NULL
a	NULL
B	NULL
lymphocyte	NULL
cDNA	NULL
library	NULL
using	NULL
cyclophilin	NULL
B	NULL
as	NULL
bait	NULL
for	NULL
endogenous	NULL
cyclophilin	NULL
ligands	NULL
(	NULL
6	NULL
)	NULL
.	NULL

When	NULL
overexpressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
this	NULL
cyclophilin-binding	NULL
protein	NULL
causes	NULL
the	NULL
calcineurin-dependent	NULL
activation	NULL
of	NULL
NFAT	NULL
,	NULL
a	NULL
T	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
responsible	NULL
for	NULL
inducing	NULL
interleukin-2	NULL
expression	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
site	NULL
of	NULL
action	NULL
of	NULL
CAML	NULL
was	NULL
determined	NULL
to	NULL
be	NULL
downstream	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
and	NULL
upstream	NULL
of	NULL
calcineurin	NULL
.	NULL

Further	NULL
support	NULL
of	NULL
a	NULL
role	NULL
for	NULL
CAML	NULL
in	NULL
calcium	NULL
signaling	NULL
was	NULL
provided	NULL
by	NULL
observations	NULL
that	NULL
CAML	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
Cancer	NULL
Center	NULL
CORE	NULL
Grant	NULL
CA-21765	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
by	NULL
Grant	NULL
BE-234	NULL
from	NULL
the	NULL
American	NULL
Cancer	NULL
Society	NULL
,	NULL
and	NULL
by	NULL
the	NULL
American	NULL
Lebanese	NULL
Syrian	NULL
Associated	NULL
Charities	NULL
(	NULL
ALSAC	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
17834	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

James	NULL
S.	NULL
McDonnell	NULL
Foundation	NULL
Scholar	NULL
,	NULL
Program	NULL
for	NULL
Molecular	NULL
Medicine	NULL
in	NULL
Cancer	NULL
Research	NULL
.	NULL

To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Experimental	NULL
Oncology	NULL
,	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
,	NULL
332	NULL
North	NULL
Lauderdale	NULL
,	NULL
Memphis	NULL
,	NULL
TN	NULL
38105	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
901-495-2613	NULL
;	NULL
Fax	NULL
:	NULL
901-495-2032	NULL
;	NULL
E-mail	NULL
:	NULL
mike	NULL
.	NULL

holloway	NULL
@	NULL
stjude.org	NULL
.	NULL

'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
CAML	NULL
,	NULL
Ca**-modulating	NULL
cyclophilin	NULL
ligand	NULL
;	NULL
SEAP	NULL
,	NULL
secreted	NULL
alkaline	NULL
phosphatase	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myris-tate	NULL
18-acetate	NULL
;	NULL
FACS	NULL
,	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
.	NULL

THs	NULL
JourNaL	NULL
or	NULL
BroLoGIcaL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

15	NULL
,	NULL
Issue	NULL
of	NULL
April	NULL
12	NULL
,	NULL
pp	NULL
.	NULL

8549-8552	NULL
,	NULL
1996	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc	NULL
.	NULL

Printed	NULL
in	NULL
U.S.A.	NULL
overexpression	NULL
relieves	NULL
the	NULL
requirement	NULL
for	NULL
increased	NULL
[	NULL
Ca**	NULL
]	NULL
;	NULL
for	NULL
activation	NULL
of	NULL
NFAT	NULL
but	NULL
does	NULL
not	NULL
relieve	NULL
the	NULL
requirement	NULL
for	NULL
protein	NULL
kinase	NULL
C	NULL
activation	NULL
.	NULL

The	NULL
sequence	NULL
analysis	NULL
of	NULL
human	NULL
CAML	NULL
failed	NULL
to	NULL
show	NULL
significant	NULL
homology	NULL
to	NULL
other	NULL
proteins	NULL
by	NULL
BLAST	NULL
and	NULL
TFASTA	NULL
algorithms	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
,	NULL
but	NULL
two	NULL
distinct	NULL
domains	NULL
are	NULL
apparent	NULL
in	NULL
hydrophobicity	NULL
plots	NULL
.	NULL

The	NULL
Goldman	NULL
,	NULL
Engelman	NULL
,	NULL
and	NULL
Steitz	NULL
hydrophobicity	NULL
scale	NULL
method	NULL
(	NULL
9	NULL
)	NULL
predicted	NULL
three	NULL
membrane-spanning	NULL
segments	NULL
in	NULL
the	NULL
C-terminal	NULL
end	NULL
of	NULL
CAML	NULL
and	NULL
a	NULL
charged	NULL
hydrophilic	NULL
N-terminal	NULL
half	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
CAML	NULL
gene	NULL
has	NULL
allowed	NULL
us	NULL
to	NULL
identify	NULL
domains	NULL
that	NULL
modulate	NULL
calcium	NULL
flux	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
the	NULL
residues	NULL
encompassing	NULL
the	NULL
last	NULL
two	NULL
putative	NULL
membrane-spanning	NULL
segments	NULL
are	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
inducing	NULL
NFAT	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
and	NULL
Deletions-The	NULL
pFLEX	NULL
expression	NULL
vector	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
27	NULL
base	NULL
pairs	NULL
that	NULL
encode	NULL
the	NULL
FLAG	NULL
epitope	NULL
into	NULL
the	NULL
pBJ5	NULL
mammalian	NULL
expression	NULL
vector	NULL
polylinker	NULL
(	NULL
10	NULL
)	NULL
.	NULL

CLX31	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
CAML	NULL
cDNA	NULL
into	NULL
pFLEX	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Plasmids	NULL
directing	NULL
expression	NULL
of	NULL
truncated	NULL
forms	NULL
of	NULL
CAML	NULL
were	NULL
made	NULL
by	NULL
standard	NULL
protocols	NULL
that	NULL
included	NULL
exonuclease	NULL
III	NULL
digestion	NULL
and	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Fragments	NULL
of	NULL
the	NULL
CAML	NULL
coding	NULL
sequence	NULL
generated	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
and	NULL
use	NULL
of	NULL
Pfu	NULL
polymerase	NULL
(	NULL
Stratagene	NULL
)	NULL
were	NULL
ligated	NULL
into	NULL
the	NULL
XAhol	NULL
and	NULL
EcoRI	NULL
restriction	NULL
endonuclease	NULL
sites	NULL
of	NULL
pFLEX	NULL
.	NULL

Plasmids	NULL
are	NULL
designated	NULL
by	NULL
the	NULL
amino	NULL
acid	NULL
residues	NULL
included	NULL
in	NULL
the	NULL
product	NULL
protein	NULL
,	NULL
with	NULL
1-296	NULL
being	NULL
the	NULL
full-length	NULL
native	NULL
protein	NULL
.	NULL

The	NULL
primer	NULL
sequences	NULL
are	NULL
listed	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

The	NULL
SXNFAT	NULL
plasmid	NULL
is	NULL
described	NULL
elsewhere	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
it	NULL
contains	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
NFAT	NULL
enhancer	NULL
element	NULL
and	NULL
the	NULL
interleukin-2	NULL
minimal	NULL
promoter	NULL
to	NULL
direct	NULL
expression	NULL
of	NULL
the	NULL
secreted	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
SEAP	NULL
)	NULL
gene	NULL
.	NULL

Cell	NULL
Culture-TAg	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
SV40	NULL
large	NULL
T	NULL
antigen	NULL
,	NULL
were	NULL
obtained	NULL
from	NULL
J.	NULL
Northrop	NULL
(	NULL
Stanford	NULL
Medical	NULL
Center	NULL
)	NULL
and	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
plus	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Gemini	NULL
Bioproducts	NULL
)	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
at	NULL
a	NULL
density	NULL
of	NULL
10°-10®	NULL
cells/ml	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
plus	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

NFAT	NULL
Functional	NULL
Assay-Mutant	NULL
CAML	NULL
expression	NULL
was	NULL
assayed	NULL
by	NULL
transient	NULL
co-transfection	NULL
with	NULL
the	NULL
NFAT	NULL
reporter	NULL
plasmid	NULL
,	NULL
SXNFAT	NULL
,	NULL
using	NULL
6	NULL
ug	NULL
of	NULL
pFLEX	NULL
or	NULL
CAML	NULL
expression	NULL
construct	NULL
,	NULL
6	NULL
ug	NULL
of	NULL
SXNFAT	NULL
,	NULL
and	NULL
2	NULL
pg	NULL
of	NULL
a	NULL
vector	NULL
expressing	NULL
luciferase	NULL
as	NULL
a	NULL
transfection	NULL
control	NULL
.	NULL

Electroporation	NULL
into	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
and	NULL
measurement	NULL
of	NULL
NFAT-SEAP	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
with	NULL
32	NULL
nm	NULL
PMA	NULL
was	NULL
used	NULL
to	NULL
activate	NULL
the	NULL
nuclear	NULL
subunit	NULL
of	NULL
NFAT	NULL
,	NULL
AP1	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
by	NULL
standard	NULL
proto-cols	NULL
.	NULL

Western	NULL
blot	NULL
assays	NULL
of	NULL
FLAG-labeled	NULL
CAML	NULL
constructs	NULL
indicated	NULL
that	NULL
the	NULL
deletion	NULL
mutants	NULL
were	NULL
correctly	NULL
expressed	NULL
in	NULL
transiently	NULL
transfected	NULL
COS	NULL
cells	NULL
.	NULL

Monoclonal	NULL
FLAG-M2	NULL
antibody	NULL
was	NULL
obtained	NULL
from	NULL
Kodak	NULL
.	NULL

FACS	NULL
Analysis-TAg	NULL
Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
6	NULL
ug	NULL
of	NULL
a	NULL
CAML	NULL
expression	NULL
vector	NULL
together	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
co-transfected	NULL
vector	NULL
expressing	NULL
mouse	NULL
CD8	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
with	NULL
rat	NULL
anti-mouse	NULL
CD8	NULL
conjugated	NULL
to	NULL
fluorescein	NULL
and	NULL
with	NULL
3	NULL
uM	NULL
indo-l1	NULL
acetoxymethyl	NULL
ester	NULL
(	NULL
Molecular	NULL
Probes	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
calcium	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
transfected	NULL
(	NULL
CD8	NULL
positive	NULL
)	NULL
cells	NULL
on	NULL
a	NULL
Becton	NULL
Dickinson	NULL
FACS	NULL
Vantage	NULL
instrument	NULL
by	NULL
determining	NULL
the	NULL
ratio	NULL
of	NULL
indo-1	NULL
fluorescence	NULL
at	NULL
400-480	NULL
nm	NULL
following	NULL
excitation	NULL
at	NULL
334-864	NULL
nm	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
CD8	NULL
plasmid	NULL
alone	NULL
served	NULL
as	NULL
the	NULL
control	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Activation	NULL
of	NULL
the	NULL
T	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
NFAT	NULL
was	NULL
assayed	NULL
by	NULL
co-transfection	NULL
of	NULL
CAML	NULL
expression	NULL
plasmids	NULL
with	NULL
the	NULL
NFAT-SEAP	NULL
plasmid	NULL
SXNFAT	NULL
.	NULL

Expression	NULL
of	NULL
SEAP	NULL
from	NULL
this	NULL
reporter	NULL
depends	NULL
on	NULL
cross-linking	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
or	NULL
stimulation	NULL
of	NULL
the	NULL
second	NULL
messengers	NULL
protein	NULL
kinase	NULL
C	NULL
8549	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
8550	NULL
Hydrophobic	NULL
Signaling	NULL
Domain	NULL
in	NULL
CAML	NULL
TaBLE	NULL
I	NULL
PCR	NULL
primers	NULL
for	NULL
deletion	NULL
analysis	NULL
Primer	NULL
sequence	NULL
is	NULL
of	NULL
the	NULL
sense	NULL
strand	NULL
for	NULL
5	NULL
primers	NULL
,	NULL
the	NULL
anti-sense	NULL
strand	NULL
for	NULL
3	NULL
``	NULL
primers	NULL
.	NULL

Sequence	NULL
in	NULL
lower	NULL
case	NULL
indicates	NULL
position	NULL
of	NULL
inserted	NULL
restriction	NULL
site	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
primer	NULL
.	NULL

Primer	NULL
Amino	NULL
acid	NULL
name	NULL
base	NULL
number	NULL
Sequence	NULL
5	NULL
'	NULL
primers	NULL
5'MH13	NULL
189	NULL
GATATctcgagTGGTGGGATGTGCTCTTCITG	NULL
5'MH14	NULL
220	NULL
GAAggatccAACTTGCGTACATGGGATTATAC	NULL
5'MH15a	NULL
240	NULL
GAAGActcgagCAACAGTACTAACAGCTGCACTTCTATTGTC	NULL
5'MH17	NULL
268	NULL
GCActcgagGCGAAGTCTTCACAGATCTCTIGTG	NULL
3	NULL
'	NULL
primers	NULL
3'MH19	NULL
146	NULL
GGCGgaattcCTCTGGACCGAGTCCTCTGTCAGGTC	NULL
3'MHSL5	NULL
201	NULL
CTCgaattcCAAGAAGAGCACATGGGAC	NULL
3'MH16	NULL
247	NULL
GATAgaattcCAGCTGTTAGTACTGTTIGTCTTIATC	NULL
3'MH12	NULL
265	NULL
GACcaattgGCTATAGGTATCCATTGATCGA	NULL
3'MHT	NULL
289	NULL
AGCcaatgAATCAAGCAGTTCATGACA	NULL
100	NULL
%	NULL
A	NULL
B	NULL
90	NULL
%	NULL
I	NULL
102	NULL
3	NULL
mae	NULL
mem	NULL
mem	NULL
.	NULL

full	NULL
length	NULL
80	NULL
%	NULL
+	NULL
1-296	NULL
70	NULL
%	NULL
+	NULL
room	NULL
.	NULL

1-25	NULL
)	NULL
§	NULL
60	NULL
%	NULL
+	NULL
geez	NULL
ees	NULL
pps	NULL
1-250	NULL
B	NULL
50	NULL
%	NULL
|	NULL
tt	NULL
22:40	NULL
:	NULL
i	NULL
e	NULL
1-201	NULL
s	NULL
___	NULL
®	NULL
40	NULL
%	NULL
+	NULL
{	NULL
_-_	NULL
-	NULL
]	NULL
mompmem	NULL
.	NULL

44-296	NULL
30	NULL
%	NULL
|	NULL
f	NULL
.	NULL

189-296	NULL
F	NULL
o	NULL
I	NULL
#	NULL
20	NULL
%	NULL
t	NULL
``	NULL
nom	NULL
.	NULL

220-289	NULL
|-10	NULL
%	NULL
gulllll0clll	NULL
.	NULL

L	NULL
nem	NULL
195-265	NULL
0	NULL
%	NULL
220-265	NULL
0	NULL
1	NULL
10	NULL
100	NULL
268-289	NULL
L_	NULL
nM	NULL
thapsigargin	NULL
nome	NULL
240-239	NULL
n	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
CAML	NULL
overexpression	NULL
on	NULL
the	NULL
Ca**	NULL
depend-	NULL
vector	NULL
ence	NULL
of	NULL
NFAT	NULL
transcription	NULL
activation	NULL
.	NULL

Cells	NULL
were	NULL
cotransfected	NULL
with	NULL
CAML	NULL
expression	NULL
plasmid	NULL
and	NULL
the	NULL
SEAP	NULL
reporter	NULL
,	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
transfected	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
0.25-12.5	NULL
nM	NULL
thapsigargin	NULL
and	NULL
32	NULL
nM	NULL
PMA	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
y	NULL
values	NULL
presented	NULL
are	NULL
the	NULL
percent	NULL
of	NULL
the	NULL
maximal	NULL
stimulation	NULL
for	NULL
each	NULL
transfection	NULL
and	NULL
are	NULL
the	NULL
average	NULL
of	NULL
three	NULL
separate	NULL
transfections	NULL
.	NULL

Assay	NULL
values	NULL
were	NULL
normalized	NULL
for	NULL
variations	NULL
in	NULL
transfection	NULL
efficiency	NULL
with	NULL
an	NULL
assay	NULL
for	NULL
co-transfected	NULL
luciferase	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
x	NULL
axis	NULL
is	NULL
log	NULL
nM	NULL
thapsigargin	NULL
.	NULL

The	NULL
zero	NULL
value	NULL
is	NULL
superimposed	NULL
on	NULL
the	NULL
graph	NULL
for	NULL
illustration	NULL
.	NULL

The	NULL
error	NULL
bars	NULL
represent	NULL
the	NULL
standard	NULL
error	NULL
.	NULL

and	NULL
Ca**	NULL
(	NULL
by	NULL
treatment	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
)	NULL
and	NULL
is	NULL
completely	NULL
blocked	NULL
by	NULL
cyclosporin	NULL
A	NULL
or	NULL
FK506	NULL
.	NULL

As	NULL
shown	NULL
previously	NULL
(	NULL
6	NULL
)	NULL
,	NULL
overexpression	NULL
of	NULL
full-length	NULL
CAML	NULL
replaced	NULL
the	NULL
usual	NULL
requirement	NULL
for	NULL
Ca**	NULL
influx	NULL
,	NULL
while	NULL
having	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
requirement	NULL
for	NULL
PMA	NULL
costimulation	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
selective	NULL
effect	NULL
on	NULL
Ca**	NULL
signaling	NULL
.	NULL

To	NULL
define	NULL
the	NULL
degree	NULL
of	NULL
activation	NULL
in	NULL
transiently	NULL
transfected	NULL
T	NULL
cells	NULL
more	NULL
precisely	NULL
,	NULL
we	NULL
developed	NULL
an	NULL
assay	NULL
comparing	NULL
the	NULL
effects	NULL
of	NULL
CAML	NULL
and	NULL
mutant	NULL
constructs	NULL
with	NULL
that	NULL
of	NULL
thapsigargin	NULL
.	NULL

Unlike	NULL
ionomycin	NULL
,	NULL
which	NULL
acts	NULL
at	NULL
both	NULL
the	NULL
endoplasmic	NULL
reticulum	NULL
and	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
thapsigargin	NULL
activates	NULL
capacitative	NULL
Ca**	NULL
influx	NULL
selectively	NULL
by	NULL
depleting	NULL
intracellular	NULL
Ca**	NULL
stores	NULL
(	NULL
15-18	NULL
)	NULL
.	NULL

NFAT	NULL
activation	NULL
in	NULL
control	NULL
cells	NULL
was	NULL
characterized	NULL
by	NULL
a	NULL
discrete	NULL
maximal	NULL
response	NULL
at	NULL
5	NULL
nm	NULL
thapsigargin	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
dotted	NULL
line	NULL
)	NULL
with	NULL
PMA	NULL
costimula-tion	NULL
.	NULL

By	NULL
marked	NULL
contrast	NULL
,	NULL
CAML	NULL
overexpression	NULL
not	NULL
only	NULL
significantly	NULL
activated	NULL
NFAT	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
thapsigargin	NULL
but	NULL
also	NULL
shifted	NULL
the	NULL
dose-response	NULL
curve	NULL
to	NULL
the	NULL
left	NULL
,	NULL
causing	NULL
a	NULL
maximal	NULL
response	NULL
at	NULL
2.5	NULL
nw	NULL
and	NULL
a	NULL
marked	NULL
enhancement	NULL
of	NULL
activation	NULL
due	NULL
to	NULL
thapsigargin	NULL
concentrations	NULL
as	NULL
low	NULL
as	NULL
250	NULL
pm	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
solid	NULL
line	NULL
)	NULL
.	NULL

A	NULL
reproducible	NULL
measure	NULL
of	NULL
CAML	NULL
activity	NULL
could	NULL
be	NULL
obtained	NULL
by	NULL
expressing	NULL
the	NULL
degree	NULL
of	NULL
activation	NULL
due	NULL
to	NULL
CAML	NULL
plus	NULL
PMA	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
maximal	NULL
activation	NULL
induced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
thapsigargin	NULL
.	NULL

To	NULL
define	NULL
the	NULL
active	NULL
residues	NULL
in	NULL
the	NULL
CAML	NULL
protein	NULL
,	NULL
we	NULL
made	NULL
10	NULL
different	NULL
deletion	NULL
mutants	NULL
and	NULL
inserted	NULL
them	NULL
into	NULL
the	NULL
eu	NULL
karyotic	NULL
expression	NULL
plasmid	NULL
pFLEX	NULL
,	NULL
which	NULL
adds	NULL
the	NULL
FLAG	NULL
5	NULL
%	NULL
15	NULL
%	NULL
35	NULL
%	NULL
55	NULL
%	NULL
75	NULL
%	NULL
%	NULL
maximal	NULL
stimulation	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Functional	NULL
assay	NULL
of	NULL
CAML	NULL
deletions	NULL
.	NULL

The	NULL
bars	NULL
on	NULL
the	NULL
left	NULL
indicate	NULL
schematically	NULL
the	NULL
residues	NULL
of	NULL
the	NULL
CAML	NULL
protein	NULL
from	NULL
amino	NULL
acid	NULL
1	NULL
to	NULL
296	NULL
encoded	NULL
by	NULL
the	NULL
expression	NULL
constructs	NULL
.	NULL

The	NULL
three	NULL
smaller	NULL
bars	NULL
on	NULL
the	NULL
top	NULL
represent	NULL
the	NULL
locations	NULL
of	NULL
the	NULL
predicted	NULL
membrane-spanning	NULL
regions	NULL
.	NULL

Values	NULL
graphed	NULL
on	NULL
the	NULL
right	NULL
represent	NULL
the	NULL
average	NULL
of	NULL
six	NULL
independent	NULL
assays	NULL
,	NULL
with	NULL
error	NULL
bars	NULL
representing	NULL
the	NULL
standard	NULL
error	NULL
.	NULL

The	NULL
assay	NULL
values	NULL
represent	NULL
CAML-induced	NULL
activation	NULL
expressed	NULL
as	NULL
percent	NULL
of	NULL
maximal	NULL
stimulation	NULL
following	NULL
treatment	NULL
with	NULL
PMA	NULL
and	NULL
thapsigargin	NULL
.	NULL

100	NULL
%	NULL
$	NULL
0	NULL
%	NULL
80	NULL
%	NULL
70	NULL
%	NULL
60	NULL
%	NULL
+	NULL
zzz	NULL
{	NULL
-+-	NULL
vector	NULL
|	NULL
|	NULL
--	NULL
240-289	NULL
)	NULL
-=-	NULL
1-250	NULL
_|	NULL
50	NULL
%	NULL
%	NULL
max	NULL
40	NULL
%	NULL
&	NULL
30	NULL
%	NULL
4	NULL
20	NULL
%	NULL
+	NULL
10	NULL
%	NULL
+	NULL
0	NULL
%	NULL
nM	NULL
thapsigarin	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Thapsigargin	NULL
titration	NULL
of	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
cotransfected	NULL
with	NULL
CAML	NULL
deletion	NULL
mutant	NULL
expression	NULL
vectors	NULL
and	NULL
the	NULL
SEAP	NULL
reporter	NULL
,	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
values	NULL
graphed	NULL
are	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1.	NULL
epitope	NULL
to	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
inserted	NULL
genes	NULL
.	NULL

Proteins	NULL
encoded	NULL
by	NULL
these	NULL
expression	NULL
plasmids	NULL
were	NULL
verified	NULL
as	NULL
being	NULL
correct	NULL
by	NULL
transfection	NULL
into	NULL
COS	NULL
cells	NULL
,	NULL
followed	NULL
by	NULL
extraction	NULL
and	NULL
Western	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Hydrophobic	NULL
Signaling	NULL
Domain	NULL
in	NULL
CAML	NULL
8551	NULL
A.	NULL
pFLEX	NULL
B.	NULL
CLX31	NULL
C.	NULL
240-289	NULL
100	NULL
120	NULL
40	NULL
60	NULL
80	NULL
20	NULL
Relative	NULL
cell	NULL
number	NULL
J	NULL
50	NULL
100	NULL
100	NULL
128	NULL
ag	NULL
_	NULL
60	NULL
.	NULL

80	NULL
20	NULL
150	NULL
200	NULL
250	NULL
Indo-1	NULL
ratio	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

FACS	NULL
analysis	NULL
of	NULL
[	NULL
Ca**	NULL
]	NULL
;	NULL
increase	NULL
induced	NULL
by	NULL
deletion	NULL
mutant	NULL
overexpression	NULL
.	NULL

The	NULL
plots	NULL
indicate	NULL
the	NULL
relative	NULL
cytoplasmic	NULL
Ca**	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
ratio	NULL
of	NULL
indo-1	NULL
fluorescence	NULL
at	NULL
480	NULL
and	NULL
400	NULL
nm	NULL
,	NULL
with	NULL
increased	NULL
Ca	NULL
``	NULL
*	NULL
corresponding	NULL
to	NULL
a	NULL
higher	NULL
ratio	NULL
on	NULL
the	NULL
abscissa	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
identified	NULL
by	NULL
co-transfection	NULL
and	NULL
detection	NULL
of	NULL
a	NULL
cell	NULL
surface	NULL
marker	NULL
(	NULL
CD8	NULL
)	NULL
.	NULL

pFLEX	NULL
is	NULL
the	NULL
parent	NULL
vector	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

CLX831	NULL
expresses	NULL
full-length	NULL
CAML	NULL
.	NULL

240-289	NULL
refers	NULL
to	NULL
the	NULL
plasmid	NULL
expressing	NULL
amino	NULL
acids	NULL
240-289	NULL
of	NULL
CAML	NULL
.	NULL

blotting	NULL
with	NULL
the	NULL
FLAG	NULL
monoclonal	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Each	NULL
protein	NULL
yielded	NULL
a	NULL
band	NULL
of	NULL
the	NULL
correct	NULL
size	NULL
on	NULL
Western	NULL
blots	NULL
,	NULL
thus	NULL
demonstrating	NULL
roughly	NULL
similar	NULL
levels	NULL
of	NULL
accumulation	NULL
.	NULL

Transfection-titration	NULL
experiments	NULL
in	NULL
Tag	NULL
Jurkat	NULL
cells	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
10	NULL
mutant	NULL
CAML	NULL
constructs	NULL
together	NULL
with	NULL
the	NULL
control	NULL
and	NULL
full-length	NULL
vectors	NULL
.	NULL

Fig	NULL
.	NULL

24	NULL
shows	NULL
the	NULL
portions	NULL
of	NULL
CAML-coding	NULL
sequence	NULL
left	NULL
in	NULL
each	NULL
construct	NULL
,	NULL
while	NULL
Fig	NULL
.	NULL

2B	NULL
indicates	NULL
the	NULL
effectiveness	NULL
of	NULL
each	NULL
construct	NULL
at	NULL
activating	NULL
NFAT	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
maximal	NULL
activation	NULL
due	NULL
to	NULL
CAML	NULL
plus	NULL
thapsigargin	NULL
.	NULL

Deletions	NULL
removing	NULL
a	NULL
portion	NULL
of	NULL
or	NULL
all	NULL
of	NULL
the	NULL
N-terminal	NULL
half	NULL
of	NULL
the	NULL
protein	NULL
had	NULL
no	NULL
important	NULL
effect	NULL
in	NULL
the	NULL
assay	NULL
(	NULL
compare	NULL
residues	NULL
189-296	NULL
with	NULL
the	NULL
full-length	NULL
1-296	NULL
)	NULL
nor	NULL
did	NULL
removal	NULL
of	NULL
the	NULL
last	NULL
seven	NULL
amino	NULL
acids	NULL
from	NULL
the	NULL
short	NULL
hydrophilic	NULL
C	NULL
terminus	NULL
(	NULL
1-289	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
removal	NULL
of	NULL
46	NULL
residues	NULL
from	NULL
the	NULL
C-terminal	NULL
end	NULL
(	NULL
1-250	NULL
)	NULL
effectively	NULL
abolished	NULL
NFAT	NULL
activity	NULL
.	NULL

To	NULL
further	NULL
localize	NULL
the	NULL
activating	NULL
activity	NULL
within	NULL
the	NULL
hydrophobic	NULL
domain	NULL
,	NULL
we	NULL
next	NULL
tested	NULL
plasmids	NULL
encoding	NULL
subregions	NULL
of	NULL
the	NULL
three	NULL
putative	NULL
transmembrane	NULL
domains	NULL
.	NULL

One	NULL
that	NULL
encoded	NULL
a	NULL
surprisingly	NULL
small	NULL
part	NULL
of	NULL
the	NULL
protein	NULL
,	NULL
the	NULL
predicted	NULL
second	NULL
and	NULL
third	NULL
membrane-spanning	NULL
regions	NULL
(	NULL
residues	NULL
240-289	NULL
)	NULL
,	NULL
was	NULL
active	NULL
in	NULL
this	NULL
assay	NULL
.	NULL

The	NULL
loop	NULL
region	NULL
(	NULL
residues	NULL
220-240	NULL
)	NULL
between	NULL
the	NULL
putative	NULL
membrane	NULL
domains	NULL
1	NULL
and	NULL
2	NULL
was	NULL
not	NULL
neces-sary	NULL
,	NULL
as	NULL
it	NULL
could	NULL
be	NULL
deleted	NULL
without	NULL
any	NULL
apparent	NULL
effect	NULL
(	NULL
compare	NULL
220-289	NULL
with	NULL
240-289	NULL
)	NULL
.	NULL

Domains	NULL
1	NULL
and	NULL
2	NULL
(	NULL
195-265	NULL
)	NULL
or	NULL
either	NULL
domain	NULL
2	NULL
or	NULL
3	NULL
alone	NULL
(	NULL
220-265	NULL
and	NULL
268-289	NULL
)	NULL
lacked	NULL
significant	NULL
activity	NULL
in	NULL
the	NULL
NFAT	NULL
assay	NULL
.	NULL

We	NULL
conclude	NULL
from	NULL
these	NULL
experiments	NULL
that	NULL
domains	NULL
2	NULL
and	NULL
3	NULL
are	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
form	NULL
the	NULL
minimum	NULL
active	NULL
fragment	NULL
of	NULL
CAML	NULL
.	NULL

This	NULL
interpretation	NULL
is	NULL
supported	NULL
by	NULL
independent	NULL
comparison	NULL
of	NULL
human	NULL
and	NULL
chicken	NULL
CAML	NULL
genes	NULL
showing	NULL
that	NULL
the	NULL
greatest	NULL
area	NULL
of	NULL
sequence	NULL
similarity	NULL
is	NULL
within	NULL
the	NULL
C	NULL
terminus	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
of	NULL
the	NULL
50	NULL
residues	NULL
within	NULL
the	NULL
240-289	NULL
domain	NULL
,	NULL
46	NULL
were	NULL
identical	NULL
between	NULL
the	NULL
two	NULL
species	NULL
and	NULL
two	NULL
others	NULL
were	NULL
highly	NULL
conserved	NULL
.	NULL

Because	NULL
overexpression	NULL
of	NULL
CAML	NULL
shifts	NULL
the	NULL
dose-response	NULL
curve	NULL
of	NULL
thapsigargin	NULL
to	NULL
lower	NULL
drug	NULL
levels	NULL
,	NULL
we	NULL
inferred	NULL
that	NULL
CAML	NULL
acts	NULL
positively	NULL
in	NULL
this	NULL
signaling	NULL
pathway	NULL
to	NULL
activate	NULL
NFAT	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
possibility	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
effect	NULL
in	NULL
any	NULL
of	NULL
the	NULL
mutant	NULL
CAML	NULL
constructs	NULL
we	NULL
similarly	NULL
investigated	NULL
dose-response	NULL
curves	NULL
for	NULL
a	NULL
shift	NULL
to	NULL
higher	NULL
thapsigargin	NULL
levels	NULL
.	NULL

The	NULL
240-289	NULL
active	NULL
fragment	NULL
,	NULL
containing	NULL
the	NULL
putative	NULL
second	NULL
and	NULL
third	NULL
membrane-spanning	NULL
domains	NULL
,	NULL
displays	NULL
elevated	NULL
NFAT	NULL
activity	NULL
and	NULL
increased	NULL
sensitivity	NULL
to	NULL
thapsigargin	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
left	NULL
shift	NULL
of	NULL
the	NULL
titration	NULL
curve	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
triangles	NULL
)	NULL
.	NULL

The	NULL
assay	NULL
results	NULL
with	NULL
this	NULL
plasmid	NULL
resemble	NULL
those	NULL
of	NULL
transfections	NULL
with	NULL
the	NULL
full-length	NULL
CAML	NULL
plasmid	NULL
,	NULL
although	NULL
the	NULL
values	NULL
are	NULL
often	NULL
higher	NULL
with	NULL
the	NULL
short	NULL
fragment	NULL
,	NULL
suggesting	NULL
the	NULL
possibility	NULL
of	NULL
an	NULL
inhibitory	NULL
or	NULL
modulatory	NULL
region	NULL
within	NULL
the	NULL
N-terminal	NULL
half	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

Each	NULL
mutant	NULL
plasmid	NULL
with	NULL
NFAT	NULL
stimulating	NULL
activity	NULL
(	NULL
1-289	NULL
,	NULL
44-296	NULL
,	NULL
189-296	NULL
,	NULL
220-289	NULL
,	NULL
and	NULL
240-289	NULL
)	NULL
also	NULL
showed	NULL
a	NULL
similar	NULL
shift	NULL
of	NULL
thapsigargin	NULL
response	NULL
to	NULL
lower	NULL
levels	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
each	NULL
of	NULL
the	NULL
inactive	NULL
mutant	NULL
plasmids	NULL
(	NULL
1-250	NULL
,	NULL
1-201	NULL
,	NULL
195-265	NULL
,	NULL
220-265	NULL
,	NULL
268-289	NULL
)	NULL
,	NULL
while	NULL
directing	NULL
appropriate	NULL
protein	NULL
expression	NULL
as	NULL
measured	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
did	NULL
not	NULL
shift	NULL
the	NULL
response	NULL
of	NULL
cells	NULL
to	NULL
thapsigargin	NULL
to	NULL
higher	NULL
levels	NULL
by	NULL
comparison	NULL
with	NULL
control	NULL
transfections	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
squares	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
can	NULL
find	NULL
no	NULL
evidence	NULL
for	NULL
a	NULL
dominant	NULL
negative	NULL
effect	NULL
of	NULL
any	NULL
of	NULL
our	NULL
constructs	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
ionomycin	NULL
titration	NULL
instead	NULL
of	NULL
thapsigargin	NULL
.	NULL

To	NULL
further	NULL
localize	NULL
the	NULL
effects	NULL
of	NULL
overexpression	NULL
of	NULL
mutant	NULL
CAML	NULL
constructs	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
calcineurin	NULL
was	NULL
an	NULL
obligate	NULL
intermediate	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NFAT	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
the	NULL
240-289	NULL
expression	NULL
plasmid	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
cyclosporin	NULL
A	NULL
at	NULL
100	NULL
ng/ml	NULL
.	NULL

Addition	NULL
of	NULL
this	NULL
immunosuppressive	NULL
level	NULL
of	NULL
cyclosporin	NULL
A	NULL
completely	NULL
abrogated	NULL
NFAT	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
our	NULL
model	NULL
in	NULL
which	NULL
this	NULL
CAML	NULL
fragment	NULL
triggers	NULL
NFAT	NULL
through	NULL
activation	NULL
of	NULL
calcineurin	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
calcineurin	NULL
was	NULL
due	NULL
to	NULL
elevation	NULL
of	NULL
Ca**	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
residue	NULL
240-289	NULL
expression	NULL
plasmid	NULL
on	NULL
cytoplasmic	NULL
Ca**	NULL
levels	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
full-length	NULL
CAML	NULL
and	NULL
those	NULL
expressing	NULL
the	NULL
240-289	NULL
deletion	NULL
mutant	NULL
were	NULL
loaded	NULL
with	NULL
indo-1	NULL
and	NULL
identified	NULL
by	NULL
staining	NULL
for	NULL
a	NULL
cell	NULL
surface	NULL
co-transfected	NULL
marker	NULL
.	NULL

Control	NULL
transfections	NULL
had	NULL
normal	NULL
resting	NULL
Ca**	NULL
fluorescence	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
,	NULL
while	NULL
cells	NULL
overexpressing	NULL
either	NULL
CAML	NULL
or	NULL
the	NULL
240-289	NULL
fragment	NULL
displayed	NULL
a	NULL
significant	NULL
number	NULL
showing	NULL
markedly	NULL
elevated	NULL
[	NULL
Ca2+	NULL
]	NULL
i	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
EGTA	NULL
to	NULL
the	NULL
cell	NULL
medium	NULL
during	NULL
the	NULL
FACS	NULL
analysis	NULL
caused	NULL
cells	NULL
with	NULL
elevated	NULL
[	NULL
Ca2+	NULL
]	NULL
i	NULL
to	NULL
drop	NULL
down	NULL
to	NULL
base	NULL
line	NULL
within	NULL
4-5	NULL
s	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
overexpression	NULL
of	NULL
this	NULL
relatively	NULL
small	NULL
peptide	NULL
is	NULL
sufficient	NULL
to	NULL
elevate	NULL
[	NULL
Ca2+	NULL
]	NULL
i	NULL
to	NULL
levels	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
full-length	NULL
protein	NULL
,	NULL
an	NULL
effect	NULL
likely	NULL
produced	NULL
by	NULL
increased	NULL
influx	NULL
of	NULL
Ca**	NULL
from	NULL
outside	NULL
the	NULL
cell	NULL
.	NULL

The	NULL
structure-function	NULL
data	NULL
presented	NULL
here	NULL
demonstrate	NULL
that	NULL
residues	NULL
240-289	NULL
of	NULL
CAML	NULL
are	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
activate	NULL
Ca**	NULL
influx	NULL
when	NULL
overexpressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
residues	NULL
overlap	NULL
the	NULL
previously	NULL
noted	NULL
transmembrane	NULL
domains	NULL
2	NULL
and	NULL
3	NULL
.	NULL

Because	NULL
the	NULL
N-terminal	NULL
half	NULL
of	NULL
the	NULL
protein	NULL
does	NULL
not	NULL
activate	NULL
Ca**	NULL
influx	NULL
and	NULL
is	NULL
not	NULL
necessary	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
240-289	NULL
fragment	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
it	NULL
may	NULL
regulate	NULL
CAML	NULL
function	NULL
under	NULL
normal	NULL
circumstances	NULL
.	NULL

However	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
a	NULL
regulatory	NULL
role	NULL
for	NULL
other	NULL
factors	NULL
(	NULL
e.g	NULL
.	NULL

altered	NULL
interference	NULL
by	NULL
interacting	NULL
proteins	NULL
or	NULL
altered	NULL
subcellular	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
8552	NULL
Hydrophobic	NULL
Signaling	NULL
Domain	NULL
in	NULL
CAML	NULL
localization	NULL
)	NULL
.	NULL

Studies	NULL
to	NULL
address	NULL
this	NULL
issue	NULL
are	NULL
under	NULL
way	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
the	NULL
modest	NULL
50-residue	NULL
fragment	NULL
of	NULL
CAML	NULL
can	NULL
activate	NULL
Ca**	NULL
influx	NULL
argues	NULL
against	NULL
an	NULL
enzymatic	NULL
role	NULL
for	NULL
CAML	NULL
in	NULL
this	NULL
context	NULL
,	NULL
since	NULL
it	NULL
seems	NULL
unlikely	NULL
that	NULL
such	NULL
a	NULL
small	NULL
peptide	NULL
could	NULL
catalyze	NULL
a	NULL
reaction	NULL
producing	NULL
a	NULL
small	NULL
second	NULL
messenger	NULL
.	NULL

We	NULL
favor	NULL
instead	NULL
a	NULL
model	NULL
in	NULL
which	NULL
this	NULL
domain	NULL
of	NULL
CAML	NULL
forms	NULL
a	NULL
direct	NULL
protein	NULL
interaction	NULL
site	NULL
by	NULL
which	NULL
it	NULL
contacts	NULL
and	NULL
activates	NULL
the	NULL
next	NULL
signaling	NULL
protein	NULL
in	NULL
the	NULL
pathway	NULL
.	NULL

The	NULL
downstream	NULL
target	NULL
of	NULL
CAML	NULL
is	NULL
currently	NULL
unknown	NULL
but	NULL
could	NULL
include	NULL
such	NULL
well	NULL
characterized	NULL
molecules	NULL
as	NULL
the	NULL
inositol	NULL
trisphosphate	NULL
receptor	NULL
or	NULL
the	NULL
endoplasmic	NULL
reticulum	NULL
Ca**	NULL
pump	NULL
or	NULL
the	NULL
hypothesized	NULL
intracellular	NULL
Ca**	NULL
leak	NULL
channel	NULL
(	NULL
20	NULL
)	NULL
.	NULL

To	NULL
date	NULL
,	NULL
we	NULL
have	NULL
not	NULL
been	NULL
able	NULL
to	NULL
ascertain	NULL
the	NULL
filling	NULL
state	NULL
of	NULL
intracellular	NULL
stores	NULL
in	NULL
CAML-overexpressing	NULL
cells	NULL
and	NULL
hence	NULL
can	NULL
not	NULL
yet	NULL
place	NULL
the	NULL
putative	NULL
target	NULL
upstream	NULL
or	NULL
downstream	NULL
of	NULL
the	NULL
site	NULL
where	NULL
the	NULL
capacitative	NULL
Ca**	NULL
influx	NULL
signal	NULL
is	NULL
gener-ated	NULL
.	NULL

Indeed	NULL
,	NULL
because	NULL
of	NULL
the	NULL
extreme	NULL
hydrophobic	NULL
nature	NULL
of	NULL
residues	NULL
240-289	NULL
,	NULL
CAML	NULL
may	NULL
itself	NULL
be	NULL
a	NULL
component	NULL
of	NULL
an	NULL
internal	NULL
Ca**	NULL
channel	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Clipstone	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
857	NULL
,	NULL
695-697	NULL
2	NULL
.	NULL

O'Keefe	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Tamura	NULL
,	NULL
J.	NULL
,	NULL
Kincaid	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Tocci	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
O'Neill	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
357	NULL
,	NULL
692-694	NULL
3	NULL
.	NULL

Liu	NULL
,	NULL
J.	NULL
,	NULL
Farmer	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Jr.	NULL
,	NULL
Lane	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Friedman	NULL
,	NULL
J.	NULL
,	NULL
Weissman	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
807-815	NULL
4	NULL
.	NULL

Fruman	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Klee	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
Bierer	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
and	NULL
Burakoff	NULL
,	NULL
8	NULL
.	NULL

J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
3686-3690	NULL
5	NULL
.	NULL

Cardenas	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Hemenway	NULL
,	NULL
C.	NULL
,	NULL
Muir	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Ye	NULL
,	NULL
R.	NULL
,	NULL
Fiorentino	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Heitman	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
5944-5957	NULL
6	NULL
.	NULL

Bram	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
871	NULL
,	NULL
355-358	NULL
7	NULL
.	NULL

Altschul	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Gish	NULL
,	NULL
W.	NULL
,	NULL
Miller	NULL
,	NULL
W.	NULL
,	NULL
Myers	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
and	NULL
Lipman	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

215	NULL
,	NULL
403-410	NULL
8	NULL
.	NULL

Pearson	NULL
,	NULL
W.	NULL
R.	NULL
,	NULL
and	NULL
Lipman	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
2444-2448	NULL
9	NULL
.	NULL

Engelman	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Steitz	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Goldman	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biophys	NULL
.	NULL

Biophys	NULL
.	NULL

Chem	NULL
.	NULL

15	NULL
,	NULL
821-353	NULL
10	NULL
.	NULL

Takebe	NULL
,	NULL
Y.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Fujisawa	NULL
,	NULL
J.	NULL
,	NULL
Hoy	NULL
,	NULL
P.	NULL
,	NULL
Yokota	NULL
,	NULL
K.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
466-472	NULL
11	NULL
.	NULL

Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Hunt	NULL
,	NULL
H.	NULL
D.	NULL
,	NULL
Horton	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Pullen	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
and	NULL
Pease	NULL
,	NULL
L.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

T7	NULL
,	NULL
51-59	NULL
12	NULL
.	NULL

Bram	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Hung	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
Martin	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
4160-4769	NULL
13	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Miner	NULL
,	NULL
Z.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Lambert	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Verdine	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
865	NULL
,	NULL
352-355	NULL
14	NULL
.	NULL

Grynkiewicz	NULL
,	NULL
G.	NULL
,	NULL
Poenie	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Tsien	NULL
,	NULL
R.	NULL
Y	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

260	NULL
,	NULL
3440-3450	NULL
15	NULL
.	NULL

Ghosh	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Eis	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Mullaney	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Ebert	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
and	NULL
Gill	NULL
,	NULL
D.	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
11075-11079	NULL
16	NULL
.	NULL

Ghosh	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Bian	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Short	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Rybak	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Gill	NULL
,	NULL
D.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
24690-24697	NULL
17	NULL
.	NULL

Takemura	NULL
,	NULL
H.	NULL
,	NULL
Ohshika	NULL
,	NULL
H.	NULL
,	NULL
Yokosawa	NULL
,	NULL
N.	NULL
,	NULL
Oguma	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Thastrup	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

180	NULL
,	NULL
1518-1526	NULL
18	NULL
.	NULL

Takemura	NULL
,	NULL
H.	NULL
,	NULL
Hughes	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Thastrup	NULL
,	NULL
O.	NULL
,	NULL
and	NULL
Putney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Jr.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
12266-12271	NULL
19	NULL
.	NULL

Bram	NULL
,	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

,	NULL
in	NULL
press	NULL
20	NULL
.	NULL

Clapham	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
259-268	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
A	NULL
Hydrophobic	NULL
Domain	NULL
of	NULL
Ca-modulating	NULL
Cyclophilin	NULL
Ligand	NULL
Modulates	NULL
Calcium	NULL
Influx	NULL
Signaling	NULL
in	NULL
T	NULL
Lymphocytes	NULL
Michael	NULL
P.	NULL
Holloway	NULL
and	NULL
Richard	NULL
J.	NULL
Bram	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:8549-8552.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.15.8549	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/15/8549	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
19	NULL
references	NULL
,	NULL
8	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
5/8549	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

